DNAnexus, a US-based provider of a cloud-based genomic analysis platform, has closed a $15m series C funding led by Claremont Creek Ventures, Google Ventures, the corporate venturing arm of internet search firm Google, TPG Biotech and First Round Capital.
Richard Daly, chief executive officer of DNAnexus, said: “This is an exciting time of growth for DNAnexus. This funding will significantly expand our capacity to support the growing number of commercial and academic labs around the world utilizing our platform to manage DNA data and analyses in a clinically appropriate manner. We welcome Claremont Creek Ventures to the team and are pleased with the continued support from Google Ventures, TPG Biotech, and First Round Capital.”
Recently, DNAnexus announced large-scale projects with Stanford University and Baylor College of Medicine.
Krishna Yeshwant, Google Ventures general partner and DNAnexus board member, said: “The next wave of insights in genetics comes from multi-institutional collaborative efforts producing huge amounts of data. DNAnexus has created a system where large enterprises, laboratories, and individuals can collaborate more efficiently using modern cloud technologies. DNAnexus is changing how global biomedical research and development markets manage DNA data and analytic infrastructures.”